About Conference
OMICS International Conferences invites all the participants across the globe to attend the "Global Summit on Melanoma and Carcinoma” slated on July 14-15, 2016 at Brisbane, Australia.
Melanoma 2016 is hosted by omics international which mainly focuses to bring experts from skin cancer. This event directs towards addressing main issues and future strategies of cancer which is going to be the largest and most promising international conference. The program provides an opportunity for participants like Oncologists, Dermatologists, Radiologists and Skin Cancer Specielists& all the entire medical team from various departments who involved in cancer care, researchers, scientists, academicians, early career individuals and patient counselors who wish to learn principles of Skin cancer cure. The conference offers to discuss and debate on various aspects of key challenges, risk factors and investment opportunities for melanoma research. It also deals with Prevention, Diagnosis, Therapy and Treatment of the Skin related Cancers and its innovative techniques. Melanoma-2016 was a two days program for staggering growth potential and revolutionizes cancer treatments over the next 10 years.
In 2009, the average age for melanoma of the skin diagnosis was 60.8 years.The risk of developing melanoma of the skin increases with age.At the end of 2007, it was estimated that, there were 136,016 people in Australia who were diagnosed with melanoma of the skin in the previous 26 years, including 45,753 people diagnosed in the previous 5 years.Relative survival rates for melanoma of the skin are higher for women than for men in Australia. The five-year relative survival from melanoma of the skin for 2006-2010 was 88.5 per cent for men and 93.6 per cent for women.In 2011, there were 1,544 deaths from melanoma of the skin (1,071 men and 473 women), accounting for 3.6 per cent of all cancer deaths in Australia.In 2014, about 14,240 Australians (8,540 men and 5700 women) are expected to be diagnosed with melanoma of the skin.In 2020, an estimated 17,570 Australians are expected to be diagnosed with melanoma of the skin.
OMICS Group International is a pioneer and leading scientific event organizer, publishing around 700+ Open access journals and conducting over 600 Scientific Meetings all over the globe annually with the support of more than 1000 scientific associations, 30,000 editorial board members, and 3.5 million followers to its credit.
Why to attend???
With members from around the world focused on learning about Melanoma and Carcinoma; this is your best opportunity to reach the largest assemblage of participants from the Melanoma community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Melanoma and Carcinoma are hallmarks of this conference.
Target Audience
- Oncologists
- Dermatologists
- Radiologists
- Consultants
- Melanoma and Carcinoma Researchers, Students
- Research scholars
- Melanoma and Carcinoma Faculty
- Medical Colleges
- Melanoma and Carcinoma Associations and Societies
- Manufacturing Medical Devices Companies
Conference Highlights
- Melanoma
- Carcinoma
- Malignant melanoma
- Melanoma and Carcinoma Causes
- Melanoma staging
- Melanoma and carcinoma: Diagnosis
- Melanoma and Carcinoma: Laboratory Diagnostic Tests
- Melanoma and Carcinoma: Treatment
- Melanoma and Carcinoma: Therapy
- Melanoma and Carcinoma: Biomarkers
- Melanoma and Carcinoma: Advance research
- Melanoma and Carcinoma: Cancer Nanotechnology
- Melanoma and Carcinoma Practice
- Oncologists
- Melanoma and carcinoma case reports
Special Issues
- All accepted abstracts will be published in respective OMICS International Journals.
- Abstracts will be provided with Digital Object Identifier by Cross Ref.
See more at: http://melanoma.cancersummit.org/
